Healthcare and animal care products company EBOS has posted double-digit profit growth, with annual revenue topping A$10 billion (NZ$11.2b) for the first time.
EBOS says its healthcare and animal care segments contributed strongly to the overall result. Photo: RNZ / Nate McKinnon
The company said healthcare and animal care segments contributed strongly to the overall result.
Despite higher costs and supply side constraints, the company also managed to lift its overall profit margin.
Key numbers for the 12 months ended June compared to a year ago:
- Net profit A$202.6 million versus A$185.3m
- Revenue A$10.73 b versus A$9.2b
- Underlying profit A$228.2m versus A$188.2m
- Underlying margin 3.1 percent versus 2.9 percent
- FY dividend 93 cents per share versus 82.5 cents per share
The company bought five businesses during the year, including Pioneer Medical, Sentry Medical, MD Solutions, LifeHealthcare and a small medical consumables distributor, which helped expand its medical consumables and medical devices distribution.
"Our double-digit revenue and earnings growth reflects a continuation of the strong first half that we announced in February 2022," EBOS chief executive John Cullity said.
"In addition, throughout the year we made investments that position the Group for continued growth in the future."
EBOS expected FY23 to be anther profitable year but with material uncertainties associated with global economic and geopolitical conditions.
Capital expenditure was also expected to remain at elevated levels as EBOS continued to focus on expansion and business upgrades.
